Zenas BioPharma, Inc. (ZBIO)
NASDAQ · Healthcare
Zenas BioPharma, Inc. Total Liabilities 2023–2025
Zenas BioPharma, Inc. annual/quarterly total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Zenas BioPharma, Inc. total liabilities for the quarter ending December 31, 2025 were 141.5M, a 146.04% increase year-over-year.
- Zenas BioPharma, Inc. total liabilities for 2025 were 141.5M, a 146.04% increase from 2024.
- Zenas BioPharma, Inc. total liabilities for 2024 were 57.5M, a 31.26% increase from 2023.
- Zenas BioPharma, Inc. total liabilities for 2023 were 43.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Zenas BioPharma, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $141 |
| 2024 | $58 |
| 2023 | $44 |
| Zenas BioPharma, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $141 |
| 2024-12-31 | $58 |
| 2023-12-31 | $44 |
Zenas BioPharma, Inc. Total Liabilities — FAQ
Zenas BioPharma, Inc. (ZBIO) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZBIO's total liabilities history?
The chart and table above show Zenas BioPharma, Inc.'s total liabilities by year and by quarter, including the growth rate.